<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4834</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2024.17101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	High-Pressure Contrast Injector: Enhancing Patient Safety and Minimizing Adverse Events&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mahendralal</surname><given-names>Kothwala Dr. Deveshkumar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Amirhamzah</surname><given-names>Shaikh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mahmadiqbal</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>Rasidmohammad</surname><given-names>Khalifa Haroonmohammad</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rajubhai</surname><given-names>Bhavsar Girakumari</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>14</day><month>01</month><year>2025</year></pub-date><volume>)</volume><issue/><fpage>1</fpage><lpage>7</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	High Pressure Contrast Injectors are widely used in modern diagnostic imaging, allowing for accurate contrast media delivery to improve visualization in angiography, CT and MRI. They optimize image quality, decreased procedure time, and minimize contrast media dosage, thus fostering patient safety and diagnostic accuracy. Enhanced features such as automatic systems and syringe heaters reduce errors and improve efficiency. Despite these advantages, there are still risks of extravasation, contrast-induced nephropathy and operator-related errors. Some mitigation strategies are rigorous training, routine maintenance, and patient screening. This review creates awareness toward recent advancements in HPCIs, their role in adverse event mitigation, and their potential to revolutionize imaging workflows to achieve safer and more effective patient care.&#13;
&#13;
</p></abstract><kwd-group><kwd>High Pressure Contrast Injectors</kwd><kwd> Catheter Angiography (X-Ray)</kwd><kwd> Computed Tomography (CT)</kwd><kwd> Contrast-Induced Nephropathy</kwd></kwd-group></article-meta></front></article>
